Read more about the article FDA Announces ‘Elsa’ AI Platform to Accelerate Drug Review and Safety Assessments
Citation: Image is used for information purposes only. Picture Credit: https://www.digitalhealthnews.com/

FDA Announces ‘Elsa’ AI Platform to Accelerate Drug Review and Safety Assessments

Prime Highlights: The FDA announced 'Elsa,' a generative AI platform that will help scientific reviewers and investigators simplify intricate workflows. Elsa improves efficiency in activities like summarizing adverse events, clinical…

Continue ReadingFDA Announces ‘Elsa’ AI Platform to Accelerate Drug Review and Safety Assessments